Lee Ainslie – NAMS history
- Issuer:
- NEWAMSTERDAM PHARMA COMPANY
- Quarters tracked:
- 7 (Q4 2024 → Q2 2026)
- Current shares:
- 3,267,802
- Current value:
- $110.75M
- Peak shares:
- 3,267,802 (Q2 2026)
- Overall change:
- +834%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 3,267,802 | $110.75M | $33.89 | +1,081,400 | +49% |
| Q1 2026 | 2,186,402 | $69.99M | $32.01 | +292,176 | +15% |
| Q4 2025 | 1,894,226 | $66.45M | $35.08 | +389,479 | +26% |
| Q3 2025 | 1,504,747 | $42.80M | $28.44 | -27,127 | -2% |
| Q2 2025 | 1,531,874 | $27.74M | $18.11 | +982,405 | +179% |
| Q1 2025 | 549,469 | $11.25M | $20.47 | +199,464 | +57% |
| Q4 2024 | 350,005 | $8.99M | $25.70 | — | NEW |